IntelliPharmaCeutics (IPC) and Vasogen, two Canadian pharmaceutical companies, are to merge, providing IPC with a listing on Nasdaq and the Toronto Stock Exchange (TSX).

Vasogen has halted development of all its drug candidates as it continues to explore "strategic alternatives".

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

In two dramatically different surgical markets, new technologies promise to improve visual access to difficult-to-reach places in the body. The first market builds on improvements in endoscopy, the second is driven by advances in diagnostic imaging.